G Calabrese, D Fantasia, R Di Gianfilippo, L Stuppia, R Di Lorenzo, G Palka. Fluorescence in situ hybridization analysis of minimal residual disease and the relevance of the der(9) deletion in imatinib-treated patients with chronic myeloid leukemia. haematol [Internet]. 2006Jul.1 [cited 2024Nov.22];91(7):994-5. Available from: https://haematologica.org/article/view/4083